Author

Ruiwen Zhang

Professor of Pharmacology and Toxicology, Robert L. Boblitt Endowed Professor in Drug Discovery - Cited by 17,530 - cancer - pharmacology - pharmaceutical sciences

Biography

Dr. Ruiwen Zhang  is currently working at Biomedical  Department. Ruiwen Zhang  is research interests includes Biomedical  in Anticancer agents. Ruiwen Zhang  serving as an editorial member and reviewer of several international reputed journals. Ruiwen Zhang  has successfully completed his Administrative responsibilities. Ruiwen Zhang  has authored of many research articles/books related to Medicine.
Title
Cited by
Year
Molecular targeting therapies for neuroblastoma: Progress and challenges
A Zafar, W Wang, G Liu, X Wang, W Xian, F McKeon, J Foster, J Zhou, ...Medicinal research reviews 41 (2), 961-1021, 2021202
124
2021
Polycomb group (PcG) proteins and human cancers: multifaceted functions and therapeutic implications
W Wang, JJ Qin, S Voruganti, S Nag, J Zhou, R ZhangMedicinal research reviews 35 (6), 1220-1267, 2015201
118
2015
Natural products targeting the p53-MDM2 pathway and mutant p53: recent advances and implications in cancer medicine
JJ Qin, X Li, C Hunt, W Wang, H Wang, R ZhangGenes & diseases 5 (3), 204-219, 2018201
72
2018
Targeting MDM2 for novel molecular therapy: Beyond oncology
W Wang, JJ Qin, M Rajaei, X Li, X Yu, C Hunt, R ZhangMedicinal research reviews 40 (3), 856-880, 2020202
52
2020
Novel natural product therapeutics targeting both inflammation and cancer
QIN Jiangjiang, W Wei, R ZhangChinese journal of natural medicines 15 (6), 401-416, 2017201
51
2017
Targeting the p53-MDM2 pathway for neuroblastoma therapy: Rays of hope
A Zafar, W Wang, G Liu, W Xian, F McKeon, J Zhou, R ZhangCancer letters 6, 16-29, 2021202
49
2021
Dihydroartemisinin selectively inhibits PDGFRα-positive ovarian cancer growth and metastasis through inducing degradation of PDGFRα protein
X Li, Q Ba, Y Liu, Q Yue, P Chen, J Li, H Zhang, H Ying, Q Ding, H Song, ...Cell discovery 3 (1), 1-13, 2017201
46
2017
Brain-and brain tumor-penetrating disulfiram nanoparticles: Sequence of cytotoxic events and efficacy in human glioma cell lines and intracranial xenografts
HR Madala, SR Punganuru, F Ali-Osman, R Zhang, KS SrivenugopalOncotarget 9 (3), 3459, 2018201
38
2018
Discovery and characterization of dual inhibitors of MDM2 and NFAT1 for pancreatic cancer therapy
W Wang, JJ Qin, S Voruganti, B Nijampatnam, SE Velu, KH Ruan, M Hu, ...Cancer research 78 (19), 5656-5667, 2018201
37
2018
Oral delivery of anti-MDM2 inhibitor SP141-loaded FcRn-targeted nanoparticles to treat breast cancer and metastasis
JJ Qin, W Wang, S Sarkar, R ZhangJournal of Controlled Release 237, 101-114, 2016201
36
2016
MDM2-NFAT1 dual inhibitor, MA242: Effective against hepatocellular carcinoma, independent of p53
W Wang, JW Cheng, JJ Qin, B Hu, X Li, B Nijampatnam, SE Velu, J Fan, ...Cancer letters 459, 156-167, 2019201
35
2019
Highly efficient delivery of potent anticancer iminoquinone derivative by multilayer hydrogel cubes
B Xue, W Wang, JJ Qin, B Nijampatnam, S Murugesan, V Kozlovskaya, ...Acta biomaterialia 58, 386-398, 2017201
33
2017
A novel inhibitor of MDM2 oncogene blocks metastasis of hepatocellular carcinoma and overcomes chemoresistance
W Wang, B Hu, JJ Qin, JW Cheng, X Li, M Rajaei, J Fan, XR Yang, ...Genes & Diseases 6 (4), 419-430, 2019201
31
2019
CTLA‑4 interferes with the HBV‑specific T cell immune response
H Cao, R Zhang, W ZhangInternational Journal of Molecular Medicine 42 (2), 703-712, 2018201
29
2018
RYBP predicts survival of patients with non-small cell lung cancer and regulates tumor cell growth and the response to chemotherapy
S Voruganti, F Xu, JJ Qin, Y Guo, S Sarkar, M Gao, Z Zheng, MH Wang, ...Cancer letters 369 (2), 386-395, 2015201
28
2015
JWA regulates TRAIL-induced apoptosis via MARCH8-mediated DR4 ubiquitination in cisplatin-resistant gastric cancer cells
Q Wang, Q Chen, L Zhu, M Chen, W Xu, S Panday, Z Wang, A Li, OD Røe, ...Oncogenesis 6 (7), e353-e353, 2017201
28
2017
Inulanolide A as a new dual inhibitor of NFAT1-MDM2 pathway for breast cancer therapy
JJ Qin, W Wang, S Sarkar, S Voruganti, R Agarwal, R ZhangOncotarget 7 (22), 32566, 2016201
27
2016
RNF185 modulates JWA ubiquitination and promotes gastric cancer metastasis
D Qiu, Q Wang, Z Wang, J Chen, D Yan, Y Zhou, A Li, R Zhang, S Wang, ...Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1864 (5 …, 2018201
26
2018
Characterization of a highly specific NQO1-activated near-infrared fluorescent probe and its application for in vivo tumor imaging
SR Punganuru, HR Madala, V Arutla, R Zhang, KS SrivenugopalScientific Reports 9 (1), 8577, 2019201
25
2019
Targeting the NFAT1-MDM2-MDMX network inhibits the proliferation and invasion of prostate cancer cells, independent of p53 and androgen
JJ Qin, X Li, W Wang, X Zi, R ZhangFrontiers in pharmacology 8, 917, 2017201
24
2017

Referred From: https://scholar.google.com/citations?user=bJYL4KsAAAAJ&hl=en

Cited by
Citations 17530
h-index 72
i10-index 203
Recommended Journals
Open Access Journals